SIGN-UP NOW! SIGN-UP NOW! Click to become a The VoiceAmerica Talk Member for Free!
voiceamerica-business radio logo
Apple logo Google Play Store Kindle store
The Ellis Martin Report

The Ellis Martin Report

Archives Available

June 21st 2017:Western Copper and Gold Update--Lexagene Pathogen detection

On today’s program Ellis speaks with Dr. Paul West-Sells, the President and CEO of Western Copper and Gold trading as WRN on the NYSE and on the TSX. The company has a large copper and gold project in the Yukon. Ellis will also speak with Dr. Jack Regan, the CEO and Founder of Lexagene, trading as LXG on the TSX-Venture Exchange and as LXXGF in the US. Lexagene has developed a fully automated pathogen detection platform which aims to transform the way organizations prevent and diagnose disease in multi-billion dollar markets such as food safety, veterinary diagnostics, water quality monit

Read more
Share Email SHARE

Tune in

Archives Available on VoiceAmerica Business Channel

Featured Guests

Guest Image

Paul West-Sells--Western Copper and Gold

Paul West-Sells , Ph. D. LinkedIn Email President & CEO Dr. West-Sells has over 20 years' experience in the mining industry. After obtaining his Ph.D. from the University of British Columbia in Metallurgical Engineering, he worked with BHP, Placer Dome, and Barrick in increasingly senior roles in Research and Development and Project Development. Dr. West-Sells has worked for Western Copper and gold since 2006, where he has held a number of technical and executive positions, and is now the President and CEO overseeing the day to day operations of the company. Dr. West-Sells sits on the Yukon Minerals Advisory Board, the Board of the Yukon Mining Alliance and is also on the Centre for Nort
Read more
Guest Image

Dr. Jack Regan-Lexagene

Dr. Jack Regan | CEO, Founder Dr. Regan invented the automated pathogen detection system that LexaGene is currently developing. He comes to LexaGene from Bio-Rad Laboratories, where he managed a team of scientists developing tests for detecting pathogens, cancer, and neurological disorders using droplet digital PCR. Prior to Bio-Rad, Jack helped QuantaLife, a startup company, bring its product from concept to commercialization. He has also worked on automated sample preparation at Applied Biosystems/Life Technologies and did his post-doctoral training at Lawrence Livermore National Laboratory, where he developed automated instruments to detect respiratory pathogens and bio-threat agents. H
Read more

Share This Episode

facebook Share On Facebook
twitter Share On Twitter
Linkedin Share On LinkedIn
Share Email Share this E-mail
Email Host Email the Host

Connect with VoiceAmerica

Download our mobile apps
App store Google play Blackberry store
GPlus Facebook Twitter Linkedin Social Media